Markets:

Overview

News

Currencies

International

Treasuries

Silexion Therapeutics Corp - Ordinary Shares (NQ:SLXN)

1.880 +0.040 (+2.17%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Silexion Therapeutics Corp - Ordinary Shares

< Previous 1 2 3 4 Next >

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

January 29, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

US Stocks Mixed; General Dynamics Earnings Top Views ↗

January 29, 2025

Via Benzinga

PESG Report: Silexion Therapeutics’ Systemic Delivery Breakthrough Positions Company as Rising Star in The Multi-Billion Dollar Precision Oncology Market

January 29, 2025

From PESG

Via Business Wire

These stocks that are showing activity before the opening bell on Wednesday. ↗

January 29, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Market Alert: PESG Releases New Report Highlighting Silexion Therapeutics as an Emerging Leader in the Multi-Billion Dollar Precision Oncology Industry

January 29, 2025

Market Alert: PESG Releases New Report Highlighting Silexion Therapeutics as an Emerging Leader in the Multi-Billion Dollar Precision Oncology Industry

Via News Direct

TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000% ↗

January 29, 2025

“Compelling” results from a study, promising pre-clinical data and a public offering got Stocktwits investors buzzing on Tuesday.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 29, 2025

Via Benzinga

US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings ↗

January 29, 2025

U.S. stock futures were mixed ahead of the crucial earnings from key U.S. technology companies and the Fed's expected pause on rate cuts.

Via Benzinga

Topics Economy

Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

January 29, 2025

Via Benzinga

Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session. ↗

January 28, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Why Is Silexion Therapeutics Stock Soaring Over 100% On Tuesday? ↗

January 28, 2025

Silexion Therapeutics shares preclinical data on SIL-204, highlighting tumor reduction in KRAS-driven cancers and sustained drug efficacy for 56+ days.

Via Benzinga

Check out the stocks that are attracting the most attention and driving market activity. ↗

January 28, 2025

Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.

Via Chartmill

Gold Gains 1%; Boeing Shares Rise Following Q4 Results ↗

January 28, 2025

Via Benzinga

These stocks are moving in today's session ↗

January 28, 2025

Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results ↗

January 28, 2025

Via Benzinga

The market is filled with gapping stocks in Tuesday's session. ↗

January 28, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings ↗

January 28, 2025

Via Benzinga

Topics Stocks

Silexion Therapeutics Highlights New Preclinical Data From Its Pancreatic Cancer Studies ↗

January 16, 2025

Silexion Therapeutics' SIL-204 exhibits synergy with key pancreatic cancer drugs in preclinical studies. Phase 2/3 trials planned for 2026.

Via Benzinga

PESG Market Update: Silexion Therapeutics’ SIL-204 Shows Groundbreaking Synergy in Preclinical Data, Boosting Hope for KRAS-Driven Cancer Treatments

January 16, 2025

From PESG

Via Business Wire

Silexion Stock Hits Record Intraday Low After Pricing $5M Offering, But Retail Excitement Over Cancer Data Endures ↗

January 16, 2025

Priced at $1.35 per share and warrant, the offering was below Wednesday’s closing price of $1.56.

Via Stocktwits

Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

January 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 16, 2025

Via Benzinga

Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket ↗

January 16, 2025

Via Benzinga

Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

December 19, 2024

Via Benzinga

PESG Releases Market Update: Silexion Therapeutics Advances KRAS-Targeting Therapies with New Collaboration As Industry Demand for Precision Oncology Solutions Rises

December 17, 2024

From PESG Research

Via Business Wire

Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

December 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 06, 2024

Via Benzinga

Agilent, Bath & Body Works And 3 Stocks To Watch Heading Into Monday ↗

November 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 21, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.